BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 6, 2020
View Archived Issues
New mouse model of MS reveals that oligodendroglia-specific connexin 47 regulates neuroinflammation
Read More
Matinas BioPharma initiates ENHANCE-IT study of MAT-9001
Read More
BioCryst initiates proof-of-concept trial of BCX-9930 in PNH
Read More
BITRAP demonstrates promising efficacy in preclinical models of rheumatoid arthritis
Read More
Servier publishes phase II data from RESTORE BRAIN study of S-44819
Read More
Phase I data for enzalutamide plus capivasertib in mCRPC
Read More
Enanta Pharmaceuticals patents MAP3K5 inhibitors
Read More
BenevolentAI Bio divulges new NTRK1 inhibitors
Read More
Blocking trash trashes MSI-hi tumors
Read More
Adlai Nortye describes hSTING receptor agonists
Read More
Il-Yang Pharmaceutical presents new antivirals
Read More
JAGUAHR Therapeutics patents new AhR antagonists
Read More
Indian approval of saroglitazar for noncirrhotic NASH
Read More
New gene fusion EWSR1-PATZ1 found in renal cell carcinoma
Read More
NCS-01 begins phase I/II study in patients with acute ischemic stroke
Read More
Enrollment open in phase I study of FT-596 for relapsed/refractory B-cell lymphoma or CLL
Read More
Gene therapy converts astrocytes into GABAergic neurons, alleviating motor deficits in HD models
Read More
Endocytosis inhibitor improves anticancer MAb efficacy
Read More
Gene rearrangements involving HMGA1/2 found in spindle cell/pleomorphic lipomas
Read More
Third cohort underway in phase I trial of Actimab-A plus CLAG-M for relapsed/refractory AML
Read More
Arcturus partners with Duke-NUS on COVID-19 vaccine development
Read More
Camrelizumab approved in China for advanced hepatocellular carcinoma
Read More